Stock Taper 
AVIDITY PARTNERS MANAGEMENT LP
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Trevi Therapeutics, Inc. | TRVI | 6.66K | $124.21K |
 Charles River Laboratories International, Inc. | CRL | 10K | $2.27M |
 BridgeBio Pharma, Inc. | BBIO | 10K | $744.8K |
 Abbott Laboratories | ABT | 10K | $907.4K |
 Legend Biotech Corporation | LEGN | 15K | $433.2K |
 Gilead Sciences, Inc. | GILD | 20K | $2.53M |
 Insulet Corp. | PODD | 24K | $3.65M |
 Encompass Health Corporation | EHC | 42K | $4.25M |
 Genmab A/S | GMAB | 50K | $1.37M |
 Avalyn Pharma Inc. Common Stock | AVLN | 60K | $1.98M |
 Palvella Therapeutics, Inc. | PVLA | 70K | $10.7M |
 Medtronic plc | MDT | 70K | $5.48M |
 Intellia Therapeutics, Inc. | NTLA | 75K | $1.27M |
 Repligen Corporation | RGEN | 77.8K | $10.62M |
 Kailera Therapeutics, Inc. | KLRA | 80K | $1.76M |
 Boston Scientific Corporation | BSX | 80K | $3.41M |
 Corvus Pharmaceuticals, Inc. | CRVS | 80K | $1.2M |
 Peloton Interactive, Inc. | PTON | 100K | $591K |
 DexCom, Inc. | DXCM | 100K | $6.74M |
 Tempus AI, Inc. | TEM | 105K | $6.08M |